Novartis Ag & Anr. vs Natco Pharma Limited on 9 April, 2024
submission that the plaintiff was bound
to disclose the X-ray diffraction pattern of the claims in the suit
patent and of Ceritinib was also ... Rules 1 and 2 of the CPC , the Court cannot
examine X-ray diffraction patterns.
(xii) The reliance of the defendant on the fact that